{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:29:48Z","timestamp":1794950988340,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:00:00Z","timestamp":1478217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Funds of China","doi-asserted-by":"crossref","award":["Grant No. 81202071"],"award-info":[{"award-number":["Grant No. 81202071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2865-1","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T23:04:16Z","timestamp":1478214256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study"],"prefix":"10.1186","volume":"16","author":[{"given":"Xuechen","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,4]]},"reference":[{"key":"2865_CR1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","volume":"26","author":"CN Landen Jr","year":"2008","unstructured":"Landen Jr CN, Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol. 2008;26:995\u20131005. doi: 10.1200\/jco.2006.07.9970 .","journal-title":"J Clin Oncol"},{"issue":"Pt 1","key":"2865_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1042\/bj3520135","volume":"352","author":"X Fang","year":"2000","unstructured":"Fang X, Yu S, LaPushin R, Lu Y, Furui T, Penn LZ, et al. Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase. Biochem J. 2000;352(Pt 1):135\u201343.","journal-title":"Biochem J"},{"key":"2865_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1006\/bbrc.1993.1651","volume":"193","author":"F Imamura","year":"1993","unstructured":"Imamura F, Horai T, Mukai M, Shinkai K, Sawada M, Akedo H. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem Biophys Res Commun. 1993;193:497\u2013503. doi: 10.1006\/bbrc.1993.1651 .","journal-title":"Biochem Biophys Res Commun"},{"key":"2865_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1023\/A:1008217129273","volume":"9","author":"AM Westermann","year":"1998","unstructured":"Westermann AM, Havik E, Postma FR, Beijnen JH, Dalesio O, Moolenaar WH, et al. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann Oncol. 1998;9:437\u201342.","journal-title":"Ann Oncol"},{"key":"2865_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/jama.280.8.719","volume":"280","author":"Y Xu","year":"1998","unstructured":"Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. Jama. 1998;280:719\u201323.","journal-title":"Jama"},{"key":"2865_CR6","first-page":"2482","volume":"6","author":"AM Eder","year":"2000","unstructured":"Eder AM, Sasagawa T, Mao M, Aoki J, Mills GB. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin Cancer Res. 2000;6:2482\u201391.","journal-title":"Clin Cancer Res"},{"key":"2865_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1006\/gyno.1998.5193","volume":"71","author":"Z Shen","year":"1998","unstructured":"Shen Z, Belinson J, Morton RE, Xu Y, Xu Y. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells. Gynecol Oncol. 1998;71:364\u20138. doi: 10.1006\/gyno.1998.5193 .","journal-title":"Gynecol Oncol"},{"key":"2865_CR8","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1158\/0008-5472.CAN-05-1292","volume":"66","author":"J Ren","year":"2006","unstructured":"Ren J, Xiao YJ, Singh LS, Zhao X, Zhao Z, Feng L, et al. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res. 2006;66:3006\u201314. doi: 10.1158\/0008-5472.can-05-1292 .","journal-title":"Cancer Res"},{"key":"2865_CR9","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1158\/0008-5472.CAN-04-0060","volume":"64","author":"D Bian","year":"2004","unstructured":"Bian D, Su S, Mahanivong C, Cheng RK, Han Q, Pan ZK, et al. Lysophosphatidic acid stimulates ovarian cancer cell migration via a Ras-MEK kinase 1 pathway. Cancer Res. 2004;64:4209\u201317. doi: 10.1158\/0008-5472.can-04-0060 .","journal-title":"Cancer Res"},{"key":"2865_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1096\/fj.02-1145fje","volume":"17","author":"S Sengupta","year":"2003","unstructured":"Sengupta S, Xiao YJ, Xu Y. A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells. Faseb j. 2003;17:1570\u20132. doi: 10.1096\/fj.02-1145fje .","journal-title":"Faseb j"},{"key":"2865_CR11","first-page":"3194","volume":"61","author":"DA Fishman","year":"2001","unstructured":"Fishman DA, Liu Y, Ellerbroek SM, Stack MS. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res. 2001;61:3194\u20139.","journal-title":"Cancer Res"},{"key":"2865_CR12","doi-asserted-by":"publisher","first-page":"10564","DOI":"10.1074\/jbc.M412152200","volume":"280","author":"H Li","year":"2005","unstructured":"Li H, Ye X, Mahanivong C, Bian D, Chun J, Huang S. Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. J Biol Chem. 2005;280:10564\u201371. doi: 10.1074\/jbc.M412152200 .","journal-title":"J Biol Chem"},{"key":"2865_CR13","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1158\/0008.5472.CAN-04-2781","volume":"65","author":"J Symowicz","year":"2005","unstructured":"Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res. 2005;65:2234\u201342. doi: 10.1158\/0008.5472.can-04-2781 .","journal-title":"Cancer Res"},{"key":"2865_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/jnci\/93.10.762","volume":"93","author":"YL Hu","year":"2001","unstructured":"Hu YL, Tee MK, Goetzl EJ, Auersperg N, Mills GB, Ferrara N, et al. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst. 2001;93:762\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"2865_CR15","doi-asserted-by":"publisher","first-page":"9653","DOI":"10.1074\/jbc.M306662200","volume":"279","author":"X Fang","year":"2004","unstructured":"Fang X, Yu S, Bast RC, Liu S, Xu HJ, Hu SX, et al. Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells. J Biol Chem. 2004;279:9653\u201361. doi: 10.1074\/jbc.M306662200 .","journal-title":"J Biol Chem"},{"key":"2865_CR16","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1158\/0008-5472.CAN-05-2947","volume":"66","author":"Z Lee","year":"2006","unstructured":"Lee Z, Swaby RF, Liang Y, Yu S, Liu S, Lu KH, et al. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer. Cancer Res. 2006;66:2740\u20138. doi: 10.1158\/0008-5472.can-05-2947 .","journal-title":"Cancer Res"},{"key":"2865_CR17","doi-asserted-by":"publisher","first-page":"27776","DOI":"10.1074\/jbc.274.39.27776","volume":"274","author":"K Bandoh","year":"1999","unstructured":"Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, et al. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem. 1999;274:27776\u201385.","journal-title":"J Biol Chem"},{"key":"2865_CR18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/mol.57.4.753","volume":"57","author":"DS Im","year":"2000","unstructured":"Im DS, Heise CE, Harding MA, George SR, O\u2019Dowd BF, Theodorescu D, et al. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol Pharmacol. 2000;57:753\u20139.","journal-title":"Mol Pharmacol"},{"key":"2865_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00428-010-0960-2","volume":"457","author":"M Tsujino","year":"2010","unstructured":"Tsujino M, Fujii M, Okabe K, Mori T, Fukushima N, Tsujiuchi T. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells. Virchows Arch. 2010;457:669\u201376. doi: 10.1007\/s00428-010-0960-2 .","journal-title":"Virchows Arch"},{"key":"2865_CR20","doi-asserted-by":"publisher","first-page":"R640","DOI":"10.1186\/bcr935","volume":"6","author":"J Kitayama","year":"2004","unstructured":"Kitayama J, Shida D, Sako A, Ishikawa M, Hama K, Aoki J, et al. Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma. Breast Cancer Res. 2004;6:R640\u20136. doi: 10.1186\/bcr935 .","journal-title":"Breast Cancer Res"},{"key":"2865_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ygyno.2012.12.007","volume":"128","author":"KP Pennington","year":"2013","unstructured":"Pennington KP, Wickramanayake A, Norquist BM, Pennil CC, Garcia RL, Agnew KJ, et al. 53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes. Gynecol Oncol. 2013;128:493\u20139. doi: 10.1016\/j.ygyno.2012.12.007 .","journal-title":"Gynecol Oncol"},{"key":"2865_CR22","first-page":"6717","volume":"62","author":"SD Yamada","year":"2002","unstructured":"Yamada SD, Hickson JA, Hrobowski Y, Vander Griend DJ, Benson D, Montag A, et al. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res. 2002;62:6717\u201323.","journal-title":"Cancer Res"},{"key":"2865_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/jnci\/90.6.447","volume":"90","author":"J Yoneda","year":"1998","unstructured":"Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst. 1998;90:447\u201354.","journal-title":"J Natl Cancer Inst"},{"key":"2865_CR24","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/bies.20081","volume":"26","author":"WH Moolenaar","year":"2004","unstructured":"Moolenaar WH, van Meeteren LA, Giepmans BN. The ins and outs of lysophosphatidic acid signaling. Bioessays. 2004;26:870\u201381. doi: 10.1002\/bies.20081 .","journal-title":"Bioessays"},{"key":"2865_CR25","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/onc.2010.517","volume":"30","author":"SY Park","year":"2011","unstructured":"Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, et al. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene. 2011;30:1351\u20139. doi: 10.1038\/onc.2010.517 .","journal-title":"Oncogene"},{"key":"2865_CR26","doi-asserted-by":"publisher","unstructured":"Komachi M, Tomura H, Malchinkhuu E, Tobo M, Mogi C, Yamada T, et al. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites. Carcinogenesis. 2009;30(3):457-65. doi: 10.1093\/carcin\/bgp011 .","DOI":"10.1093\/carcin\/bgp011"},{"key":"2865_CR27","doi-asserted-by":"publisher","first-page":"C1927","DOI":"10.1152\/ajpcell.00400.2006","volume":"292","author":"M Chen","year":"2007","unstructured":"Chen M, Towers LN, O\u2019Connor KL. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. Am J Physiol Cell Physiol. 2007;292:C1927\u201333. doi: 10.1152\/ajpcell.00400.2006 .","journal-title":"Am J Physiol Cell Physiol"},{"key":"2865_CR28","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/labinvest.3700146","volume":"84","author":"D Shida","year":"2004","unstructured":"Shida D, Watanabe T, Aoki J, Hama K, Kitayama J, Sonoda H, et al. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Invest. 2004;84:1352\u201362. doi: 10.1038\/labinvest.3700146 .","journal-title":"Lab Invest"},{"key":"2865_CR29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.ygyno.2006.10.016","volume":"104","author":"P Wang","year":"2007","unstructured":"Wang P, Wu X, Chen W, Liu J, Wang X. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms. Gynecol Oncol. 2007;104:714\u201320. doi: 10.1016\/j.ygyno.2006.10.016 .","journal-title":"Gynecol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2865-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-016-2865-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2865-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T04:03:17Z","timestamp":1568520197000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2865-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2865"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2865-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,4]]},"article-number":"846"}}